Molecular mechanisms and therapeutic strategies of chronic renal injury: Renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis

Journal of Pharmacological Sciences

Volumn 100, Issue 1, 2006, Pages 22-28

  Nishikimi, Toshio ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Fasudil; Glomerulosclerosis; Hypertension; Rho kinase; Transforming growth factor

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FASUDIL; RHO FACTOR; RHO KINASE; RHO KINASE INHIBITOR;

CELL INFILTRATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; KIDNEY INJURY; MACROPHAGE; MOLECULAR MECHANICS; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; RENAL PROTECTION; SHORT SURVEY; UPREGULATION;

EID: 31544433970     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FMJ05003X5     Document Type: Short Survey

References (21)

1. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001;81:153-208.
2. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001;22:32-39.
3. Uehata T, Ishizaki H, Satoh T, Ono T, Kawahara T, Morishita H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
4. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol. 2002;40:751-761.
5. Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 2002;61:1684-1695.
6. Satoh S, Yamaguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I, et al. Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol. 2002;455:169-174.
7. Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y, et al. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens. 2004;22:1787-1796.
8. Adnane J, Seijo E, Chen Z, Bizouarn F, Leal M, Sebti SM, et al. RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1. J Biol Chem. 2002;277:8500-8507.
9. Border WA, Noble NA. Cytokines in kidney disease: the role of transforming growth factor-β. Am J Kidney Dis. 1993;22:105-113.
10. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int. 2003;64:2009-2019.
11. Ishikawa Y, Nishikimi T, Mori Y, Ishimura K, Akimoto K, Tadokoro K, et al. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in malignant hypertensive rats partly via inhibition of oxydative stress. Circulation. 2004;110:S63.
12. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4:446-456.
13. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res. 2003;93:767-775.
14. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004;24:1842-1847.
15. Horwitz AR, Parsons JT. Cell migration - movin' on. Science. 1999;286:1102-1103.
16. Border WA, Noble NA. Cytokines in kidney disease: the role of transforming growth factor-β. Am J Kidney Dis. 1993;22:105-113.
17. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int. 2001;59:87-95.
18. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 2002;39:269-274.
19. Mezzetti A, Cipollone F, Cuccurullo F. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res. 2000;47:475-488.
20. Klahr S. The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant. 2001;16 Suppl1:60-62.
21. Yamori Y, Nara Y, Mizushima S, Murakami S, Ikeda K, Sawamura M, et al. Gene-environment interaction in hypertension, stroke and atherosclerosis in experimental models and supportive findings from a world-wide cross-sectional epidemiological survey: a WHO-cardiac study. Clin Exp Pharmacol Physiol Suppl. 1992;20:43-52.